January 22 – Year-end report 2024
Alligator hosted a webinar on Wednesday, January 22, at 3 p.m. CET for investors, analysts and media, where CEO Søren Bregenholt and CFO Johan Giléus presented and commented on the Year-end report, which was followed by a Q&A session.
The call was held in English and can be requested through the link below.
LATEST NEWS
Alligator Bioscience determines record date for reverse share split of ordinary shares and reminds of the recalculation of warrants
The board of directors of Alligator Bioscience AB (“Alligator Bioscience” or the “Company”) has resolved that the re …
Change in number of shares and votes in Alligator Bioscience AB
During March 2025, the number of shares and votes in Alligator Bioscience AB (“Alligator Bioscience”) has increased as a result …
Alligator Bioscience publishes Annual Report for 2024
Lund, Sweden, 27 March 2025 – Alligator Bioscience (Nasdaq Stockholm: ATORX) today announced that the Annual Report for 2024, as well …